Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNFL measured by OCT to depict axonal loss in early RRMS treated with different doses of subcutaneous interferon beta-1a
2009-015007-97Phase 4Completed
- Sponsor
- Dr. Enrico Montanari
- Start
- Oct 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of interferon beta-1a in multiple sclerosis (MS) (2 arms), sponsored by Dr. Enrico Montanari. Started Oct 2009; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-015007-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015007-97.